|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2007-11-16
|
|
pubmed:abstractText |
The incidence of gram-positive and mixed bacterial infections in surgical patients has increased, and there has been an alarming rise in the number of drug-resistant bacteria. Peptidoglycan (PepG) is a cell wall component of gram-positive bacteria that stimulates inflammatory responses both ex vivo and in vivo. The systemic effects of PepG on inflammation have not been studied in a large animal model.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1096-2964
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
495-503
|
|
pubmed:meshHeading |
pubmed-meshheading:17999582-Animals,
pubmed-meshheading:17999582-Hemodynamics,
pubmed-meshheading:17999582-Humans,
pubmed-meshheading:17999582-Inflammation,
pubmed-meshheading:17999582-Interleukin-6,
pubmed-meshheading:17999582-Interleukin-8,
pubmed-meshheading:17999582-Lipopolysaccharides,
pubmed-meshheading:17999582-Male,
pubmed-meshheading:17999582-Peptidoglycan,
pubmed-meshheading:17999582-Swine,
pubmed-meshheading:17999582-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Activation of cytokine synthesis by systemic infusions of lipopolysaccharide and peptidoglycan in a porcine model in vivo and in vitro.
|
|
pubmed:affiliation |
Institute for Surgical Research, Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway. tomruud@online.no
|
|
pubmed:publicationType |
Journal Article,
In Vitro
|
